AstriVax is a vaccine platform company that secured €30 million in a large seed round to build a first in class Plug & Play vaccine platform with a patented DNA based technology. The versatile technology, launching self-amplifying live attenuated viruses with additional antigens, can be used to develop a wide range of prophylactic and therapeutic vaccines.
Our mission is to address real-world challenges in vaccinology by developing novel vaccines that have single dose potential, are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.
Our mission is to address real-world challenges in vaccinology by developing novel vaccines that have single dose potential, are easy to produce, have reduced cold chain requirements, and offer broad and long-lasting protection against various viruses and other pathogens.
Focus Areas
BIO DOUBLE HELIX SPONSORS
BIO HELIX SPONSORS
